These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-001487-32 Evaluation of Corticosteroids on Idiopathic Sudden Sensorineural Hearing Loss not-yet-due
Completed, but no date 2007-000729-24 Coagulation effect of four common plasma volume expanders bad-data
Ongoing 2007-003017-14 A comparison of the effect of Atropine and Botulinum-toxin in patients with severe drooling not-yet-due
Ongoing 2008-001309-40 Pharmacogenetic of propofol not-yet-due
Ongoing 2009-011784-37 Does teriparatide lower the risk for loosening of a knee prosthesis? not-yet-due
Not reported 2009-014414-98 The impact of local bisphosphonate treatment on prosthetic fixation 2015-07-30 due-trials
Not reported 2009-017320-29 Does teriparatide accelerate early callus formation in proximal humeral fractures? 2013-06-10 due-trials
Not reported 2010-022715-19 Inflammation och koagulation vid habituell abort 2016-07-27 due-trials
Not reported 2011-000254-39 Perioperative Goal Directed Fluid Therapy during Esophageal Resection. A prospective randomized controlled open multi-centre trial to study the effect on postoperative complications 2015-10-14 due-trials
Completed, but no date 2011-002917-12 Does PTH enhance healing after spinal fusion? Förbättrar PTH postero-lateral fusionsläkning vid ryggkirurgi? bad-data
Ongoing 2011-004829-27 Påverkar valet av smärtlindring vid tjocktarm/ändtarmscancer recidiv och överlevnad? (EPICOL-studien). not-yet-due
Not reported 2011-005700-15 Can 5-HT3 receptor antagonists be used to limit vomiting in rota- and norovirus infections? Kan 5-HT3 receptorantagonister användas för att begränsa kräkningar vid rota- och norovirusinfektion? 2015-06-26 due-trials
Completed, but no date 2011-006241-15 GLUTAmate for Metabolic Intervention in Coronary Surgery II Metabol intervention med glutamat vid operation för ischemisk hjärtsjukdom bad-data
Reported results 2012-003251-11 Pilot Trial to preserve residual insulin secretion in children and adolescents with recent onset Type 1 diabetes by using GAD-antigen (Diamyd) therapy in combination with Vitamin D and Ibuprofen . 2017-03-31 due-trials
Ongoing 2012-005797-58 Contraception after gastric bypass - part three How does gastric bypass affect the pharmacocinetics of oral desogestrel? Antikonception efter fetmakirurgi- delstudie 3 Hur påverkar fetmakirurgi m... not-yet-due
Completed, report not yet due Terminated 2013-004726-28 Double-blind randomised controlled study to down regulate allergic responses in adults with allergic rhinoconjunctivitis by using three intralymphatic injections of grass and/or birch allergen one mon... 2023-11-16 not-yet-due
Reported results 2013-005565-40 Optical measurement with 5-ALA during surgical resection of brain tumors in children Optisk mätning med 5-ALA vid kirurgisk resektion av hjärntumör hos barn 2018-10-28 due-trials
Reported results 2014-001323-76 Open Label trial to evaluate the tolerability of a combination therapy consisting of GAD-alum (Diamyd®), etanercept and vitamin D in children and adolescents newly diagnosed with type 1 diabetes 2019-02-25 due-trials
Exempt, with results 2014-001417-79 Open Label Pilot Trial in patients with recent-onset T1D to evaluate the safety, diabetes status and immune response of GAD-antigen (Diamyd®) therapy administered into lymph nodes in combination with ... 2019-10-08 not-yet-due
Completed, but no date, and reported results Terminated 2014-003844-11 Continous treatment with bevacizumab in elderly patients with mCRC: an open label, single arm, prospective phase IV trial to evaluate outcome and safety of continuous bevacizumab treatment in combinat... bad-data
Ongoing 2014-004677-17 Contraception after gastric bypass - part 4 How does gastric bypass affect the pharmacocinetics of oral levonorgestrel? Antikonception efter fetmakirurgi - delstudie 4 Hur påverkar fetmakirurgi med... not-yet-due
Completed, but no date 2015-003903-51 Effect of omeprazole intake on faecal calprotectin Påverkan av omeprazol på fekalt calprotectinvärde bad-data
Completed, report not yet due Terminated 2016-003369-24 Double-blind randomised controlled study to down regulate allergic responses in adults with allergic rhinoconjunctivitis by using three intralymphatic injections of grass and birch allergen or placebo... 2023-11-16 not-yet-due
Reported results 2016-004082-39 An Open-Label Phase II Study in anti-GBM disease (Goodpasture’s disease) with Adverse Renal Prognosis to Evaluate the Efficacy and Safety of IdeS --GOOD-IDES Eine offene Phase II Studie zur Evaluie... 2020-07-31 due-trials
Ongoing 2016-005013-47 Effects of the FAAH inhibitor PF-04457845 on fear extinction in healthy volunteers not-yet-due
Not reported 2017-000317-22 A pilot study of low dose acetylsalicylic acid (ASA) for reduction of breast density and inflammation 2020-09-28 due-trials
Reported results 2017-001945-29 Immediate post partum LNG-IUS insertion or standard insertion procedure after childbirth An open-label, randomized, multicenter study 2021-01-21 due-trials
Reported results 2017-004624-30 Modulating proinflammatory processes using tocilizumab in major depressive disorder 2019-11-05 due-trials
Ongoing 2018-004829-82 Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers not-yet-due
Completed, reported early 2020-004487-25 Experiencing the self through touch - self-other-distinction in an altered state of self: An exploratory randomized placebo-controlled experimental medicine study 2023-11-25 not-yet-due
Ongoing 2021-001059-15 The value of 99mTc-MIP-1404 SPECT/CT Veriton CZT for staging of prostate cancer and before primary therapy and in biochemical recurrence after radical prostatectomy. Fase II study. Titel: Rollen av... not-yet-due
Completed, report not yet due 2021-005441-32 DIAGNODE-B, A Phase I/II Open Label Pilot Study to evaluate the safety and feasibility of an additional intralymphatic booster administration of GAD-alum (Diamyd®) in individuals with Type 1 diabetes 2023-08-29 not-yet-due